Literature DB >> 29292551

Bias from outcome misclassification in immunization schedule safety research.

Sophia R Newcomer1,2, Martin Kulldorff3, Stan Xu1, Matthew F Daley1,4, Bruce Fireman5, Edwin Lewis5, Jason M Glanz1,2.   

Abstract

PURPOSE: The Institute of Medicine recommended conducting observational studies of childhood immunization schedule safety. Such studies could be biased by outcome misclassification, leading to incorrect inferences. Using simulations, we evaluated (1) outcome positive predictive values (PPVs) as indicators of bias of an exposure-outcome association, and (2) quantitative bias analyses (QBA) for bias correction.
METHODS: Simulations were conducted based on proposed or ongoing Vaccine Safety Datalink studies. We simulated 4 studies of 2 exposure groups (children with no vaccines or on alternative schedules) and 2 baseline outcome levels (100 and 1000/100 000 person-years), with 3 relative risk (RR) levels (RR = 0.50, 1.00, and 2.00), across 1000 replications using probabilistic modeling. We quantified bias from non-differential and differential outcome misclassification, based on levels previously measured in database research (sensitivity > 95%; specificity > 99%). We calculated median outcome PPVs, median observed RRs, Type 1 error, and bias-corrected RRs following QBA.
RESULTS: We observed PPVs from 34% to 98%. With non-differential misclassification and true RR = 2.00, median bias was toward the null, with severe bias (median observed RR = 1.33) with PPV = 34% and modest bias (median observed RR = 1.83) with PPV = 83%. With differential misclassification, PPVs did not reflect median bias, and there was Type 1 error of 100% with PPV = 90%. QBA was generally effective in correcting misclassification bias.
CONCLUSIONS: In immunization schedule studies, outcome misclassification may be non-differential or differential to exposure. Overall outcome PPVs do not reflect the distribution of false positives by exposure and are poor indicators of bias in individual studies. Our results support QBA for immunization schedule safety research.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  bias (epidemiology); database; electronic health records; immunization; pharmacoepidemiology; safety; sensitivity and specificity

Mesh:

Substances:

Year:  2018        PMID: 29292551      PMCID: PMC5800415          DOI: 10.1002/pds.4374

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  38 in total

1.  The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise.

Authors:  Michael Nguyen; Robert Ball; Karen Midthun; Tracy A Lieu
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

Review 2.  Identifying health outcomes in healthcare databases.

Authors:  Stephan Lanes; Jeffrey S Brown; Kevin Haynes; Michael F Pollack; Alexander M Walker
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-08-18       Impact factor: 2.890

3.  Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.

Authors:  Meghan A Baker; Michael Nguyen; David V Cole; Grace M Lee; Tracy A Lieu
Journal:  Vaccine       Date:  2013-12-30       Impact factor: 3.641

4.  How far from non-differential does exposure or disease misclassification have to be to bias measures of association away from the null?

Authors:  Anne M Jurek; Sander Greenland; George Maldonado
Journal:  Int J Epidemiol       Date:  2008-01-09       Impact factor: 7.196

5.  Identifying optimal risk windows for self-controlled case series studies of vaccine safety.

Authors:  Stanley Xu; Lijing Zhang; Jennifer C Nelson; Chan Zeng; John Mullooly; David McClure; Jason Glanz
Journal:  Stat Med       Date:  2010-11-30       Impact factor: 2.373

6.  Potential sensitivity of bias analysis results to incorrect assumptions of nondifferential or differential binary exposure misclassification.

Authors:  Candice Y Johnson; W Dana Flanders; Matthew J Strickland; Margaret A Honein; Penelope P Howards
Journal:  Epidemiology       Date:  2014-11       Impact factor: 4.822

Review 7.  The Vaccine Safety Datalink: a model for monitoring immunization safety.

Authors:  James Baggs; Julianne Gee; Edwin Lewis; Gabrielle Fowler; Patti Benson; Tracy Lieu; Allison Naleway; Nicola P Klein; Roger Baxter; Edward Belongia; Jason Glanz; Simon J Hambidge; Steven J Jacobsen; Lisa Jackson; Jim Nordin; Eric Weintraub
Journal:  Pediatrics       Date:  2011-04-18       Impact factor: 7.124

8.  Pediatric vaccination and vaccine-preventable disease acquisition: associations with care by complementary and alternative medicine providers.

Authors:  Lois Downey; Patrick T Tyree; Colleen E Huebner; William E Lafferty
Journal:  Matern Child Health J       Date:  2010-11

9.  Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule.

Authors:  Matthew F Daley; Jason M Glanz; Sophia R Newcomer; Michael L Jackson; Holly C Groom; Marlene M Lugg; Huong Q McLean; Nicola P Klein; Eric S Weintraub; Michael M McNeil
Journal:  Vaccine       Date:  2017-03-09       Impact factor: 3.641

Review 10.  The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.

Authors:  Michael M McNeil; Julianne Gee; Eric S Weintraub; Edward A Belongia; Grace M Lee; Jason M Glanz; James D Nordin; Nicola P Klein; Roger Baxter; Allison L Naleway; Lisa A Jackson; Saad B Omer; Steven J Jacobsen; Frank DeStefano
Journal:  Vaccine       Date:  2014-08-06       Impact factor: 3.641

View more
  2 in total

Review 1.  A primer on quantitative bias analysis with positive predictive values in research using electronic health data.

Authors:  Sophia R Newcomer; Stan Xu; Martin Kulldorff; Matthew F Daley; Bruce Fireman; Jason M Glanz
Journal:  J Am Med Inform Assoc       Date:  2019-12-01       Impact factor: 4.497

Review 2.  Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.

Authors:  Lana Yh Lai; Faaizah Arshad; Carlos Areia; Thamir M Alshammari; Heba Alghoul; Paula Casajust; Xintong Li; Dalia Dawoud; Fredrik Nyberg; Nicole Pratt; George Hripcsak; Marc A Suchard; Dani Prieto-Alhambra; Patrick Ryan; Martijn J Schuemie
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.